Read by 100K+ Stem Cell Execs, Investors, & Scientists
Access breaking stem cell news, before your competition.
“I greatly appreciate BioInformant’s efforts to educate, update and inform. I have found Cade’s writings to be a very useful way to keep up on what my colleagues and other companies are doing and reporting at meetings I am unable to attend. Keep up the good work.”
Kevin Hicok Director of Research and Development, VetStem Biopharma
“BioInformant is a great place to get updates and share valuable information and ideas in cell therapy. With tremendous technological breakthroughs not yet translated to successes in the market, the awareness created by Bioinformant is much needed and helpful. Thank you to the knowledgeable and dedicated team that makes this happen.”
Dr. Yael Margolin President & CEO, Gamida Cell
“BioInformant is the most useful central repository of real-time information in the field of Regenerative and Translational Medicine. The resources provided for scientists, clinicians, patients, and other industry professionals interested in learning what is happening in real-time is truly invaluable. The accuracy of the information, timeliness of the information, and quality of the information make BioInformant an invaluable resource.”
Joseph Krieger Founder, Boston Biolife
“We are impressed with Bioinformant, and encourage those interested in the field to follow them for up-to-date news.
Barbara Nelsen, PhD, MBA Founder, Nelsen Biomedical
“Being new to the sector, I’ve found BioInformant an invaluable resource for getting me up to speed about the cord blood and stem cells industry. They’re also a supportive organisation that genuinely wants our business to succeed! We look forward to continuing our partnership.”
Michael Adeniya Commercial Director, Phacilitate Ltd.
“As Head of Global Outreach for Save the Cord Foundation, I am constantly working with our partners to explore creative and effective ways to promote cord blood awareness on a global level. BioInformant understands and appreciates our mission. They continue to be very pro-active in working with us and we have reached new audiences as a result. As partners in cord blood education, we share a passion for the industry and geniunely care about its future which we all agree has so much potential.”
Rachel Manley Head of Global Outreach, Save the Cord Foundation
“It was a tremendous pleasure working with BioInformant, as they were always very accessible and cooperative. I look forward to working with BioInformant in the very near future on other projects. Cade was also very helpful in writing an article on the First Annual Inter American Stem Cell Conference to be held in Havana, Cuba on October 13-15, 2016.”
Ricardo de Cubas President, Founder, & CEO - Regenestem
“Neo Matrix would like to extend a heartfelt thanks to Bioinformant and CEO Cade Hildreth in your profound dedication and passion in heading up the premier social media platform for stem cell therapy across the globe.
The presentation of the most recent, continuously updated, and groundbreaking international scientific research is paving the way to help providers bridge the gap between stem cell clinical research and therapeutic applications.”
Bobby Ardila V.P. International Communications of Neo Matrix, LLC
“BioInformant is a market research leader—there is undoubtedly no more comprehensive and unbiased cell therapy research firm in the industry. CEO Cade Hildreth is both passionate and professional about the growth and evolution of this field and, ultimately, bringing new options to patients which push forward the need of progress in medicine.”
Corina Froese Director of Educational Relations at Okyanos www.Okyanos.com
“BioInformant is the serious, comprehensive and sole-focused source on stem cell research and therapy. As a result, Cade Hildreth’s market research, interviews and blogs have become my go-to source for information. She and her team provide the facts, statistics and insights that interest me. I look forward to Bioinformant leading the stem cell market forward!”
Matthew Feshbach CEO and Co-Founder of Okyanos www.Okyanos.com
“Bioinformant is a wonderful and balanced source of information about cell therapies-covering all aspects of the area including existing clinical therapies, research, pipeline products and more! It’s a source I trust to keep up with this rapidly evolving field.”
Dr. Chris Centeno CEO at Regenexx www.Regenexx.com
“BioInformant is the best site on the leaders in the field, a must read for regenerative medicine.”
Hank MacDonald Blogger at Investor Stem Cell www.InvestorStemCell.com
“Bioinformant is professional and knowledgeable, reports accurately and operates with integrity. We’ve done three stories together. Looking forward to the next.”
Marjie Hada Public Relations / Communications www.MPH-PR.com
“I would like to express my genuine feelings of gratitude for BioInformant’s exellent work. BioInformant is the most complete information source in the evolution of stem cell history.”
Prof Dr Ramon Albert President of ITERA Life-Sciences consortium www.itera-lifesciences.org
BioInformant is unquestionably the leader in covering stem cell industry news, market progress, and breakthroughs. Cade has firsthand experience with the power of our own stem cells to revolutionize the practice or medicine and transform lives.
Claire Hooper Administrator of Adult Stem Cell Advocates
Bioinformant is truly amazing in how quickly they respond and get back to you to deliver quality proven technology to the biotech industry.
Gary Harlem President of Altucell inc. (Altucell.com)
“Cade sees the real potential, direction and growing global platform for all aspects of cord blood stem cells. BioInformant believes and knows the science is hard, real and it’s happening now, not someday or in the distant future.”
Charis Ober Co-Founder Save the Cord Foundation www.savethecordfoundation.org
“BioInformant has been diligent about supporting our specific goals and investigations. Most importantly, our interactions with BioInformant management have been great!
They’ve helped us to grow sales and better understand our clients.”
Hakon Birgisson PhD, MBA Director of Global Market Development ORF Genetics www.OrfGenetics.com
“BioInformant puts enormous time and effort into their products, which are accurate and precise. Their cord blood industry knowledge is outstanding, so cord blood banks and investors actively seek out their expertise.”
Sonja Seeburger Business Development Manager Market Reports www.MarketReports.com
“The BioInformant team was great to work with. The cord blood report we claimed was comprehensive and informative and the team was extremely responsive to all of our questions. I would highly recommend them to anyone interested in learning more about the cord blood and cord tissue markets.”
Kevin Cox Private Equity Analyst, Audax Group www.audaxgroup.com
“I am now truly enlightened. You are awesome! I must say it has been an absolute pleasure working with you folks. You will always get a great customer recommendation from me.”
John Jaskowiak Vice President, Angiocrine Bioscience www.angiocrinebioscience.com
“I was truly impressed by BioInformant. You can trust BioInformant to do things right and generate greater awareness of your technology. They are the go-to resource for stem cell researchers and companies looking for trustworthy stem cell business information and marketing support.”
Dr. William Frey II Founder and Co-Director Alzheimer’s Research Center www.alzheimersinfo.org
“A special effort was made to render this excellent report accessible to us. The discussions that followed were very helpful, and will contribute to the realization of our objective which is to establish a public cord blood bank in sub-Saharan Africa.”
Michael S. Pepper, MBChB, PhD, MD Director, Institute for Cellular & Molecular Medicine, University of Pretoria
“Many thanks for your willingness to contribute to the progress of the stem cell field. You exude tremendous enthusiasm and it translates into your words and your work. Thank you for sharing that energy with us.”
João Andrade CEO & Co-Founder WideCELLS (London, England)